Neuron23
South San Francisco, CA
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
neuron23.comCompany Details
Founded
- 2018
Employees
- Between 20 - 100 employees
Raised
- $310,000,000
Headquarters Location
- South San Francisco, CA
Public
- No
Acquired
- No
CEO
Nancy Stagliano
Founders
- Mike NallsAdam Knight
Company Collections
These are collections Neuron23 is a part of. Click on the collection name to view similar companies.
Neuron23's Investors
Neuron23's Industries
Neuron23 Headquarters Location
681 Gateway Blvd, South San Francisco, CA 94080
Total Amount Raised: $310,000,000
Neuron23's Investors
Neuron23 Funding Rounds
Series D
$96,500,000
Series D Investors
SoftBank Vision FundRedmile GroupKleiner PerkinsHBM Healthcare InvestmentsAcorn BioventuresWestlake Village BioPartnersBlue OwlSeries C
$100,000,000
Series C Investors
SoftBank Vision FundHBM Healthcare InvestmentsWestlake Village BioPartnersKleiner PerkinsHBM PartnersRedmile GroupPerceptive AdvisorsAcorn BioventuresCOWENSurveyor CapitalSeries A
$33,500,000
Series A Investors
Kleiner PerkinsWestlake Village BioPartnersSeries B
$80,000,000
Series B Investors
Redmile GroupSurveyor CapitalCOWENAcorn BioventuresHBM PartnersKleiner PerkinsWestlake Village BioPartnersPerceptive AdvisorsHBM Healthcare Investments
Funding info provided by Diffbot.
Neuron23 Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Neuron23.